Position in LXRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$395,217
+$138,326 QoQ
Shares Held
164,674
0.0% QoQ
Ownership
0.037%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#44
of 148 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LXRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ikarian Capital, LLC holds $559,861,982 across 103 Biotechnology names. LXRX ranks #87 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
|
328,635 | $43,793,900 | |
| 2 | KOD |
Kodiak Sciences Inc.
|
1,059,730 | $41,287,080 | |
| 3 | ALMS |
Alumis Inc.
|
870,548 | $24,497,220 | |
| 4 | PRAX |
Praxis Precision Medicines, Inc.
|
72,842 | $24,386,773 | |
| 5 | PCVX |
Vaxcyte, Inc.
|
388,682 | $22,594,084 | |
| 6 | CLDX |
Celldex Therapeutics, Inc.
|
478,500 | $17,804,985 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
504,559 | $15,555,553 | |
| 8 | RLMD |
Relmada Therapeutics, Inc.
|
2,148,359 | $14,866,644 |
All Filings in LXRX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $395,217 | 164,674 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $256,891 | 164,674 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $189,375 | 164,674 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $238,246 | 176,479 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $167,655 | 176,479 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $652,257 | 1,417,952 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,147,000 | 1,550,000 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||